Medical Marijuana Abstracts 7

Medical Marijuana Abstracts 7

My Thanks to David Worrell at FaceBook for finding all these articles

Phytocannabinoids as novel therapeutic agents in CNS disorders

Alabama Medical Marijuana Patients Rights Act

Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress

GPR55 CB3Placenta

Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells

Identification of cannabinoid type 1 receptor in dog hair follicles

Opposing Roles for Cannabinoid Receptor Type-1 (CB(1)) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats

Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection

Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates

Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine